Consumer Health Healthcare
ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces it has entered into a Letter of Intent ("LOI") t...
July 02, 2026 | News
SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or activ...
June 30, 2026 | News
4DMedical Limited (ASX: 4DX), the global leader in advanced respiratory imaging, announced that CT:VQ™ technology has Therapeutic Goods Adminis...
June 30, 2026 | News
S-CELL, a premier innovator in cellular health and anti-aging biotechnology, today announced the launch of its advanced metabolic support synbiotic (Prebio...
June 29, 2026 | News
Ask the region’s clinical-operations leaders whether decentralised and hybrid trials are the future, and the answer is almost unanimous. Surveys keep...
June 26, 2026 | Analysis
ZEISS Medical Technology and Envision Health Technologies will collaborate to advance the next generation of patient-accessible, software-driven visual fun...
June 22, 2026 | News
Ethics approval received from the Alfred Hospital Human Research Ethics Committee (Bayside Health) for Phase 2b KappaMab™ clinical trial “HLX...
June 22, 2026 | News
-- Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, congratulates its portfolio company Rejuvenate...
June 15, 2026 | News
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...
June 10, 2026 | News
As healthcare systems across Asia Pacific confront mounting workforce shortages, ageing populations, and rising chronic disease burdens, artificial intelli...
June 10, 2026 | News
The collaboration aims to improve access to lifestyle coaching supported, clinically guided programs for patients exploring medical weight care. NOVI Heal...
June 04, 2026 | News
Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex® (bulevirtide-gmod...
May 27, 2026 | News
Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development ...
May 20, 2026 | News
Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development ...
May 20, 2026 | News
Most Read
Bio Jobs
News
Editor Picks